| Literature DB >> 33996382 |
Anthony J Garcia-Prats1,2, Ryan M McAdams1, Mogomotsi Matshaba3,4,5, Lineo Thahane4,5,6, Sabrina M Butteris1, James H Conway1, Mandy Slutsker7, Nicole E St Clair1, Heather Haq4,5.
Abstract
PURPOSE OF REVIEW: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), continues to affect individuals, communities, and health systems worldwide. Here, we highlight how COVID-19 threatens to jeopardize the tremendous gains made over the last few decades on improving children's health globally. RECENTEntities:
Keywords: Food insecurity; Healthcare workforce; Low- and middle-income countries (LMICs); Malnutrition; Mental health; Routine childhood immunization
Year: 2021 PMID: 33996382 PMCID: PMC8112470 DOI: 10.1007/s40475-021-00241-6
Source DB: PubMed Journal: Curr Trop Med Rep
Priority actions to mitigate impacts of COVID-19 on global child health
| 1. Increase financial and technical support to high-need countries that foster local responses to mitigate the effects of COVID-19 on child health. Responses should be informed by shared evidence and international best practices but should be adapted to local contexts and must be driven by local health leadership and communities [ | |
| 2. Rapidly and freely disseminate lessons learned and share best practices and guidelines, including open access to COVID-related scientific publications, so that practitioners in all settings can benefit from evolving knowledge and each other’s experiences [ | |
| 3. Ensure equitable distribution of PPE globally to protect all healthcare workers. Widely disseminate innovative methods to optimally create or reuse PPE, such as through safe decontamination. Support engineering and manufacturing of PPE locally, focusing on items that can be easily decontaminated and used safely and effectively multiple times. | |
| 4. Support ongoing programs that provide non-COVID-19 priority preventive and curative care for children, such as antenatal and neonatal care; immunization programs; nutrition support; diagnosis and treatment of diarrheal illness, pneumonia, TB, and HIV care; early childhood development programs; child protection services; and care of noncommunicable diseases, including through innovative delivery models [ | |
| 5. Ensure timely, equitable inclusion of children in clinical trials of COVID-19 vaccines and therapeutics, and ultimately rapid, affordable, and equitable access for all children globally to any of these that prove to be effective. | |
| 6. Fund COVID-19 research in children with comorbidities to characterize the risk of severe disease, establish care protocols, determine therapeutic interventions, and determine prioritization for COVID-19 vaccination. |